Okay, let's tackle this question about Congenital Nephrotic Syndrome due to Nephrin mutations. First, I need to recall what Nephrin is and its role. Nephrin is a key component of the slit diaphragm in the glomerular filtration barrier. Mutations in the NPHS1 gene cause congenital nephrotic syndrome of the Finnish type, right?

The question is asking which statement is false. The options aren't provided, but I need to think of common misconceptions or incorrect facts related to this condition. Let's consider possible options.

Common facts about this condition: It's a cause of congenital nephrotic syndrome, presents in the first few months of life, massive proteinuria, hypoalbuminemia, edema. It's autosomal recessive. Treatment might involve supportive care, sometimes dialysis or transplantation. Prognosis is poor without treatment.

Possible false statements could be: Onset in adulthood (but it's congenital), autosomal dominant inheritance (but it's recessive), response to steroids (but it's steroid-resistant), or maybe something about the gene being NPHS2 instead of NPHS1. Also, maybe a false claim about treatment options, like ACE inhibitors being effective (they might be used but not curative).

So if the options include statements like "It is autosomal dominant," "Responds well to corticosteroids," "Caused by NPHS2 mutation," or "Onset after age 1 year," those would be incorrect. Let's structure the explanation around these points. Need to make sure each part of the explanation is accurate and addresses why the false option is wrong. Also, the clinical pearl should highlight the key features to remember for exams.

**Core Concept**
Congenital nephrotic syndrome (CNS) caused by *NPHS1* gene mutations leads to defective nephrin, a critical component of the glomerular slit diaphragm. This disrupts the filtration barrier, causing massive proteinuria and hypoalbuminemia.

**Why the Correct Answer is Right**
Mutations in *NPHS1* (not *NPHS2*) cause Finnish-type CNS, an autosomal recessive disorder. The disease presents in infancy with severe proteinuria, edema, and hyperlipidemia. It is steroid-resistant, requiring supportive management like diuretics, albumin infusions, or renal replacement therapy.

**Why Each Wrong Option is Incorrect**
**Option A:** If claiming "onset in adulthood," this is false—CNS due to nephrin mutations presents in the first 3 months of life.
**Option B:** If stating "autosomal dominant inheritance," it’s incorrect—this condition is autosomal recessive.
**Option C:** If suggesting "responds to corticosteroids," this is wrong—steroids are ineffective in this steroid-resistant form.
**Option D:** If attributing the mutation to *NPHS2* (encoding podocin), this is false—*NPHS1* encodes nephrin, while *NPHS2* mutations cause steroid-resistant nephrotic syndrome type 2.

**Clinical Pearl / High-Yield Fact**
Remember: *NPHS1* mutations → **nephrin deficiency** → **Finnish-type CNS**

✓ Correct Answer: D. Should manifest within 1st 2 weeks of life